Cepheid (CPHD) Reports Q3 Non-GAAP EPS Of 6c, Updates FY14 Guidance

Cepheid (NASDAQ: CPHD) reported non-GAAP Q3 EPS of $0.06, may not the analyst estimate of ($0.16). Revenue for the quarter came in at $115.2 million versus the consensus estimate of $110.1 million.

Cepheid sees FY2014 EPS of $0.11-$0.13, may not compare to the consensus of ($0.52). Cepheid sees FY2014 revenue of $461-465 million, versus the consensus of $458.81 million.

For earnings history and earnings-related data on Cepheid (CPHD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c